| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonography, Computed Tomographic | 12 | 2024 | 16 | 3.460 |
Why?
|
| Tomography, X-Ray Computed | 17 | 2024 | 2093 | 1.760 |
Why?
|
| Radiation Exposure | 3 | 2019 | 42 | 1.620 |
Why?
|
| Radiology | 4 | 2023 | 106 | 1.230 |
Why?
|
| Colorectal Neoplasms | 7 | 2024 | 576 | 1.190 |
Why?
|
| Multidetector Computed Tomography | 7 | 2021 | 34 | 1.160 |
Why?
|
| Rectal Neoplasms | 3 | 2022 | 78 | 1.060 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 5 | 2017 | 9 | 1.050 |
Why?
|
| Contrast Media | 11 | 2023 | 480 | 1.040 |
Why?
|
| Biocompatible Materials | 6 | 2021 | 117 | 1.010 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 362 | 0.980 |
Why?
|
| Radiation Dosage | 6 | 2019 | 135 | 0.930 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 690 | 0.860 |
Why?
|
| Computed Tomography Angiography | 4 | 2024 | 198 | 0.850 |
Why?
|
| Collagen | 4 | 2023 | 317 | 0.830 |
Why?
|
| Biliary Tract | 1 | 2022 | 15 | 0.790 |
Why?
|
| Gallstones | 1 | 2022 | 18 | 0.770 |
Why?
|
| Choledocholithiasis | 1 | 2022 | 14 | 0.760 |
Why?
|
| Cathartics | 2 | 2023 | 28 | 0.760 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 146 | 0.700 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 140 | 0.650 |
Why?
|
| Sensitivity and Specificity | 9 | 2022 | 2057 | 0.620 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 3603 | 0.610 |
Why?
|
| Patient Positioning | 1 | 2019 | 55 | 0.600 |
Why?
|
| Liver Neoplasms | 6 | 2020 | 1316 | 0.580 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1293 | 0.570 |
Why?
|
| Medical Errors | 1 | 2019 | 154 | 0.550 |
Why?
|
| Phantoms, Imaging | 2 | 2016 | 134 | 0.530 |
Why?
|
| Radiometry | 1 | 2016 | 38 | 0.530 |
Why?
|
| Body Size | 1 | 2017 | 55 | 0.530 |
Why?
|
| Colon | 2 | 2021 | 352 | 0.520 |
Why?
|
| Tendons | 1 | 2016 | 41 | 0.510 |
Why?
|
| Crohn Disease | 1 | 2019 | 279 | 0.510 |
Why?
|
| Blood Volume | 1 | 2016 | 81 | 0.510 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 225 | 0.510 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 378 | 0.500 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 80 | 0.490 |
Why?
|
| Hyaluronic Acid | 4 | 2020 | 96 | 0.490 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 2904 | 0.470 |
Why?
|
| Blood Flow Velocity | 1 | 2016 | 456 | 0.460 |
Why?
|
| Humans | 55 | 2024 | 125466 | 0.460 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 778 | 0.450 |
Why?
|
| Regeneration | 1 | 2016 | 211 | 0.440 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 2519 | 0.440 |
Why?
|
| Algorithms | 3 | 2022 | 1633 | 0.440 |
Why?
|
| Intestinal Perforation | 1 | 2014 | 56 | 0.430 |
Why?
|
| Osseointegration | 3 | 2023 | 7 | 0.410 |
Why?
|
| Titanium | 3 | 2023 | 20 | 0.410 |
Why?
|
| Lung | 1 | 2020 | 1487 | 0.410 |
Why?
|
| Middle Aged | 25 | 2024 | 26833 | 0.400 |
Why?
|
| Aged | 18 | 2024 | 19747 | 0.390 |
Why?
|
| Diet | 2 | 2023 | 1139 | 0.370 |
Why?
|
| Neoadjuvant Therapy | 3 | 2022 | 344 | 0.370 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 1549 | 0.330 |
Why?
|
| Colonoscopy | 6 | 2024 | 238 | 0.330 |
Why?
|
| Hydrogels | 4 | 2020 | 83 | 0.320 |
Why?
|
| Coronary Angiography | 2 | 2024 | 449 | 0.320 |
Why?
|
| Male | 31 | 2024 | 61637 | 0.310 |
Why?
|
| Polyesters | 2 | 2020 | 39 | 0.300 |
Why?
|
| Radiation Protection | 3 | 2017 | 54 | 0.280 |
Why?
|
| Alloys | 3 | 2023 | 13 | 0.280 |
Why?
|
| Adult | 15 | 2024 | 29642 | 0.280 |
Why?
|
| Diagnostic Imaging | 3 | 2024 | 280 | 0.270 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 2184 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2019 | 586 | 0.260 |
Why?
|
| Aged, 80 and over | 9 | 2022 | 6559 | 0.260 |
Why?
|
| Coronary Aneurysm | 2 | 2017 | 33 | 0.250 |
Why?
|
| Clinical Protocols | 2 | 2021 | 240 | 0.250 |
Why?
|
| Female | 24 | 2024 | 66904 | 0.240 |
Why?
|
| Radiographic Image Enhancement | 5 | 2018 | 42 | 0.240 |
Why?
|
| Chemoradiotherapy | 2 | 2022 | 104 | 0.230 |
Why?
|
| Osteogenesis | 2 | 2023 | 154 | 0.230 |
Why?
|
| Kidney Calculi | 1 | 2024 | 43 | 0.230 |
Why?
|
| Femoral Fractures | 1 | 2024 | 32 | 0.220 |
Why?
|
| Retrospective Studies | 9 | 2023 | 16362 | 0.220 |
Why?
|
| Neoplasm Staging | 3 | 2024 | 1275 | 0.220 |
Why?
|
| Radiography | 2 | 2023 | 809 | 0.220 |
Why?
|
| Kidney Neoplasms | 2 | 2019 | 440 | 0.210 |
Why?
|
| Prospective Studies | 9 | 2024 | 6174 | 0.210 |
Why?
|
| Lung Volume Measurements | 1 | 2023 | 75 | 0.210 |
Why?
|
| Omentum | 1 | 2023 | 48 | 0.210 |
Why?
|
| Genomics | 2 | 2023 | 1520 | 0.210 |
Why?
|
| Chitosan | 1 | 2023 | 20 | 0.210 |
Why?
|
| Bariatric Surgery | 1 | 2024 | 120 | 0.200 |
Why?
|
| Signal-To-Noise Ratio | 3 | 2017 | 41 | 0.200 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 8 | 0.190 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2022 | 10 | 0.190 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2017 | 282 | 0.190 |
Why?
|
| Endosonography | 1 | 2022 | 78 | 0.190 |
Why?
|
| Body Weights and Measures | 1 | 2021 | 42 | 0.190 |
Why?
|
| Hernia, Hiatal | 1 | 2021 | 56 | 0.180 |
Why?
|
| Bone Substitutes | 1 | 2021 | 10 | 0.180 |
Why?
|
| Radiography, Abdominal | 2 | 2011 | 48 | 0.180 |
Why?
|
| Reference Values | 2 | 2020 | 719 | 0.180 |
Why?
|
| Thalassemia | 1 | 2020 | 11 | 0.170 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2020 | 26 | 0.170 |
Why?
|
| Endocardium | 1 | 2020 | 51 | 0.170 |
Why?
|
| Drainage | 1 | 2022 | 260 | 0.170 |
Why?
|
| Ultrasonography, Interventional | 1 | 2022 | 189 | 0.170 |
Why?
|
| Achilles Tendon | 1 | 2020 | 10 | 0.170 |
Why?
|
| Tendon Injuries | 1 | 2020 | 17 | 0.170 |
Why?
|
| Betacoronavirus | 2 | 2020 | 291 | 0.170 |
Why?
|
| Gastroesophageal Reflux | 2 | 2021 | 327 | 0.170 |
Why?
|
| Esophagus | 1 | 2021 | 223 | 0.160 |
Why?
|
| Observer Variation | 1 | 2020 | 300 | 0.160 |
Why?
|
| Machine Learning | 1 | 2022 | 251 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 142 | 0.160 |
Why?
|
| Radiotherapy Setup Errors | 1 | 2019 | 1 | 0.160 |
Why?
|
| Myocarditis | 1 | 2020 | 130 | 0.160 |
Why?
|
| Supine Position | 1 | 2019 | 25 | 0.160 |
Why?
|
| Obesity | 3 | 2024 | 2251 | 0.160 |
Why?
|
| Prone Position | 1 | 2019 | 33 | 0.160 |
Why?
|
| Preoperative Care | 3 | 2021 | 353 | 0.160 |
Why?
|
| Vascular Calcification | 1 | 2019 | 56 | 0.150 |
Why?
|
| Iopamidol | 1 | 2017 | 5 | 0.140 |
Why?
|
| Young Adult | 3 | 2023 | 9086 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2012 | 49 | 0.140 |
Why?
|
| ROC Curve | 1 | 2019 | 572 | 0.140 |
Why?
|
| Enema | 1 | 2017 | 37 | 0.140 |
Why?
|
| Surface Properties | 3 | 2023 | 83 | 0.140 |
Why?
|
| Electric Impedance | 1 | 2017 | 63 | 0.140 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2017 | 39 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1070 | 0.140 |
Why?
|
| Collagen Type I | 3 | 2023 | 112 | 0.140 |
Why?
|
| Liver Diseases | 2 | 2011 | 368 | 0.140 |
Why?
|
| Coronary Artery Disease | 2 | 2024 | 805 | 0.130 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 240 | 0.130 |
Why?
|
| Pandemics | 2 | 2020 | 1113 | 0.130 |
Why?
|
| Stents | 1 | 2022 | 835 | 0.130 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 42 | 0.130 |
Why?
|
| Diverticulum, Colon | 1 | 2015 | 4 | 0.120 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2023 | 38 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2022 | 12305 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2016 | 163 | 0.120 |
Why?
|
| Spleen | 1 | 2016 | 280 | 0.120 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 185 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 221 | 0.110 |
Why?
|
| Postgastrectomy Syndromes | 1 | 2013 | 2 | 0.110 |
Why?
|
| Time Factors | 3 | 2021 | 6323 | 0.110 |
Why?
|
| Rabbits | 3 | 2021 | 717 | 0.110 |
Why?
|
| Femur | 1 | 2013 | 67 | 0.110 |
Why?
|
| Carcinoma | 1 | 2016 | 290 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2016 | 654 | 0.110 |
Why?
|
| Neoplasms | 2 | 2022 | 2800 | 0.110 |
Why?
|
| Colonic Polyps | 1 | 2014 | 78 | 0.100 |
Why?
|
| Melanoma | 1 | 2020 | 943 | 0.100 |
Why?
|
| Gastrectomy | 1 | 2013 | 93 | 0.100 |
Why?
|
| Iodine | 1 | 2012 | 22 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2024 | 1900 | 0.100 |
Why?
|
| Informed Consent | 1 | 2015 | 333 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 855 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2016 | 887 | 0.090 |
Why?
|
| Vancomycin | 1 | 2013 | 217 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 933 | 0.090 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 175 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 239 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 185 | 0.090 |
Why?
|
| Sulfur | 1 | 2011 | 13 | 0.090 |
Why?
|
| Epidural Space | 1 | 2011 | 23 | 0.090 |
Why?
|
| Absorbable Implants | 2 | 2013 | 24 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 1315 | 0.090 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2011 | 68 | 0.090 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 362 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2016 | 3043 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2020 | 295 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 462 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2019 | 4843 | 0.080 |
Why?
|
| Cicatrix | 1 | 2011 | 124 | 0.080 |
Why?
|
| Global Health | 1 | 2014 | 569 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 562 | 0.080 |
Why?
|
| HIV Infections | 1 | 2020 | 1896 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2013 | 491 | 0.070 |
Why?
|
| Asymptomatic Diseases | 2 | 2020 | 83 | 0.070 |
Why?
|
| Prostheses and Implants | 2 | 2021 | 152 | 0.070 |
Why?
|
| Cross-Linking Reagents | 2 | 2005 | 55 | 0.060 |
Why?
|
| Incidental Findings | 2 | 2017 | 126 | 0.060 |
Why?
|
| Body Fluids | 1 | 2005 | 47 | 0.060 |
Why?
|
| Adolescent | 1 | 2023 | 19448 | 0.060 |
Why?
|
| Contraindications | 2 | 2015 | 78 | 0.060 |
Why?
|
| Fractures, Closed | 1 | 2024 | 9 | 0.060 |
Why?
|
| Angina Pectoris | 1 | 2024 | 57 | 0.060 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 76 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 22 | 0.050 |
Why?
|
| Liver | 1 | 2010 | 1749 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4691 | 0.050 |
Why?
|
| Bone Matrix | 1 | 2023 | 8 | 0.050 |
Why?
|
| Sulfates | 1 | 2002 | 35 | 0.050 |
Why?
|
| Viscosity | 1 | 2002 | 36 | 0.050 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2022 | 46 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 2429 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2023 | 347 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2022 | 95 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2023 | 240 | 0.050 |
Why?
|
| Animals | 6 | 2021 | 34309 | 0.040 |
Why?
|
| Durapatite | 1 | 2020 | 17 | 0.040 |
Why?
|
| Bioprospecting | 1 | 2020 | 1 | 0.040 |
Why?
|
| Drug Stability | 1 | 2020 | 58 | 0.040 |
Why?
|
| Biopsy | 2 | 2016 | 1243 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 57 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2020 | 387 | 0.040 |
Why?
|
| Orthopedics | 1 | 2021 | 67 | 0.040 |
Why?
|
| Pericarditis | 1 | 2020 | 42 | 0.040 |
Why?
|
| Ipilimumab | 1 | 2020 | 63 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 824 | 0.040 |
Why?
|
| Sutures | 1 | 2020 | 64 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 276 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 160 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 972 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2021 | 241 | 0.040 |
Why?
|
| Feces | 1 | 2023 | 727 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2022 | 605 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 245 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 266 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 779 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 1096 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1242 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1192 | 0.030 |
Why?
|
| Colon, Descending | 1 | 2015 | 3 | 0.030 |
Why?
|
| Colon, Ascending | 1 | 2015 | 8 | 0.030 |
Why?
|
| Colon, Sigmoid | 1 | 2015 | 13 | 0.030 |
Why?
|
| Colon, Transverse | 1 | 2015 | 6 | 0.030 |
Why?
|
| Cecal Diseases | 1 | 2015 | 6 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 678 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 114 | 0.030 |
Why?
|
| Occult Blood | 1 | 2015 | 31 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 71 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 306 | 0.030 |
Why?
|
| Body Weight | 1 | 2018 | 989 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2014 | 69 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3727 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 2015 | 94 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 762 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 186 | 0.030 |
Why?
|
| Iohexol | 1 | 2012 | 21 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 977 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1756 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3310 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 644 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1282 | 0.020 |
Why?
|
| Adhesiveness | 1 | 2011 | 12 | 0.020 |
Why?
|
| Biopolymers | 1 | 2011 | 20 | 0.020 |
Why?
|
| Rheology | 1 | 2011 | 33 | 0.020 |
Why?
|
| Absorption | 1 | 2011 | 52 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1980 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 30 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2012 | 344 | 0.020 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2011 | 28 | 0.020 |
Why?
|
| Syringes | 1 | 2011 | 25 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1534 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 426 | 0.020 |
Why?
|
| Reoperation | 1 | 2013 | 830 | 0.020 |
Why?
|
| Patient Safety | 1 | 2015 | 398 | 0.020 |
Why?
|
| Angiography | 1 | 2010 | 210 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1703 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2828 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 2469 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1156 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1019 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1692 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 3136 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10301 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2005 | 7 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 75 | 0.020 |
Why?
|
| History, Ancient | 1 | 2005 | 53 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 144 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 3440 | 0.020 |
Why?
|
| Materials Testing | 1 | 2005 | 72 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2005 | 391 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 426 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 773 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 3743 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 4405 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 1399 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 17743 | 0.010 |
Why?
|